Unlocking the Potential of Radio Darpin Therapy: Molecular Partners to Showcase Promising Preclinical Data at AACR Conference
Targeted Radionuclide Delivery Platform Strengthened by New Safety and Mechanistic Data Overview Exciting advancements are on the horizon in the field of targeted radionuclide delivery, as Molecular Partners prepares to present new safety and mechanistic data at the American Association for Cancer Research Annual Meeting 2023. This significant event will shed light on the high…